SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹10 Cr | ₹8.57 Cr | ₹7.09 Cr | ₹6.83 Cr | ₹6.40 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SAKAR HEALTHCARE ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹10 Cr |
Mar2023 | ₹8.57 Cr |
Mar2022 | ₹7.09 Cr |
Mar2021 | ₹6.83 Cr |
Mar2020 | ₹6.40 Cr |
How is Deferred Tax Assets / Liabilities of SAKAR HEALTHCARE Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹10 Cr | 16.94 | |
Mar2023 | ₹8.57 Cr | 20.87 | |
Mar2022 | ₹7.09 Cr | 3.88 | |
Mar2021 | ₹6.83 Cr | 6.75 | |
Mar2020 | ₹6.40 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of SAKAR HEALTHCARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAKAR HEALTHCARE | ₹727.8 Cr | -0.8% | -3.4% | 6.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,383.0 Cr | 1.8% | -3.6% | -7.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,026.0 Cr | -2.8% | -12.1% | 24% | Stock Analytics | |
CIPLA | ₹126,159.0 Cr | 2.3% | 2.4% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,450.0 Cr | 2.9% | 6.5% | 8.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,536.0 Cr | 2% | -2.4% | -13.1% | Stock Analytics |
SAKAR HEALTHCARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAKAR HEALTHCARE | -0.8% |
-3.4% |
6.4% |
SENSEX | -0% |
-2.1% |
1.1% |
You may also like the below Video Courses